CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sprint Bioscience AB Company Snapshot
Sprint Bioscience AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sprint Bioscience AB with three other companies in this sector in Sweden: Genovis AB (2017 sales of 22.87 million Swedish Kronor [US$2.50 million] of which 100% was Medical Research Tools), Saniona AB (20.69 million Swedish Kronor [US$2.26 million] ), and Xbrane Biopharma Ab (20.77 million Swedish Kronor [US$2.27 million] of which 108% was Long-acting injectables).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sprint Bioscience AB
  Stock Performance Chart for Sprint Bioscience AB
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 10.20
(Figures in Swedish Kronor)
1 Week -14.3%   13 Weeks -39.5%  
4 Weeks -27.1%   52 Weeks -62.9%  
 
Sprint Bioscience AB Key Data:
  Ticker: SPRINT Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 23,965,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 103,017,766
  Fiscal Yr Ends: December Shares Outstanding: 10,099,781
  Share Type: Aktie Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.